Cardiac Science raises $8.7 million:
This article was originally published in Clinica
Executive Summary
Cardiac Science has raised $8.7 million through a private placement. The Irvine, California-based company claims it has developed the only external defibrillator that continuously monitors in-hospital patients at risk of sudden cardiac arrest. If necessary, the product administers a shock within seconds, without the aid of hospital staff. The company will use the proceeds for the global marketing of its Powerheart ECD, which it plans to launch this quarter.